Incident UV radiation leads to the upregulation of vascular endothelial growth factor (VEGF), a potent angiogenic factor, in human skin. However, the molecular basis of UV-induced angiogenesis in skin remains to be elucidated. In this study, we investigated the roles of UV exposure on cutaneous angiogenesis, its associated signaling mechanisms, and the effect of all-trans retinoic acid (tRA) on UV-induced vascularization, and VEGF expression. Using a human epidermal cell line, HaCaT, we found that UV induces VEGF mRNA and protein expression via the MAPK/ERK kinase-ERK1/2 (extracellular signal-regulated kinase 1/2) pathway but not via the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, and that tRA pretreatment significantly inhibits UV-induced VEGF overexpression and ERK1/2 activation. In human skin in vivo, we confirmed that skin vascularization significantly increased after a single exposure to UV, as was evidenced by a prominent increase in vessel size, vascular density, and in the cutaneous area occupied by vessels, and we found that these events are associated with VEGF upregulation. Topical pretreatment with tRA under occlusion inhibited not only UV-induced VEGF upregulation and angiogenesis with a significant reduction of vessel density but also UV-induced ERK1/2 activation in human skin. Collectively, our data demonstrate that tRA inhibits the UV-induced angiogenic switch via downmodulation of ERK1/2 activation and consecutive VEGF overexpression. These findings may help us understand the molecular mechanisms that regulate skin angiogenesis due to UV exposure, and provide evidence of the potential of tRA in terms of preventing angiogenesis-associated skin damage following exposure to UV irradiation.
INTRODUCTION
Human skin is exposed daily to solar UV radiation and the epidermis is a primary target for UV radiation. Chronic exposure of skin to UV radiation leads to photoaging and photocarcinogenesis (Clydesdale et al., 2001; Ichihashi et al., 2003) . Recently, it was reported that a single exposure to UV radiation may induce vascular hyperpermeability, dermal blood vessel dilation, and lead to an imbalance between angiogenic factors and inhibitors in human skin (Yano et al., 2005) . Angiogenesis, the process of generating new capillary blood vessels, is accompanied with physiological and pathological conditions of skin (Detmar, 2000; Velasco and Lange-Asschenfeldt, 2002) . However, the molecular basis and regulation of angiogenesis-associated skin damages induced by acute UV exposure remain unclear.
It is accepted that epidermal keratinocytes have a primary role in the physiology and pathology of cutaneous angiogenesis (Malhotra et al., 1989) . Moreover, epidermis-derived vascular endothelial growth factor (VEGF) is regarded as a potent angiogenic factor in many cutaneous diseases (Bowden et al., 2002; Gira et al., 2004) . VEGF is a homodimeric, heparin-binding glycoprotein that also binds to specific receptors, which are mainly expressed in endothelial cells. Alternative splicing of the original mRNA transcript generates at least five different VEGF isoforms (Bates et al., 2002) , the 121, 165, and 189 amino-acid isoforms of which predominate in human keratinocytes (Ballaun et al., 1995) . The expression of VEGF in both immortalized and cultured keratinocytes is increased by several stimulants, for example, oxidants, TNF-a, and keratinocyte growth factor (Frank et al., 1995; Brauchle et al., 1996) . In particular, several reports have suggested that VEGF is induced in human keratinocytes after UV exposure (Mildner et al., 1999; Blaudschun et al., 2000) .
The retinoids consist of vitamin A (retinol), and its naturally occurring and synthetic derivatives, many of which are potent agents for the treatment of different skin disorders, such as acne, psoriasis, photoaging, and cancer (Roos et al., 1998) . They modulate cell growth and differentiation in skin (Fisher and Voorhees, 1996) , and inhibit angiogenesis, endothelial cell migration and carcinogenesis in skin cancers (Lingen et al., 1998; Pal et al., 2000) . Moreover, recent studies have demonstrated that retinoids inhibit basal VEGF expression in cultured keratinocytes and human skin grafted onto nude mice (Lachgar et al., 1999; Diaz et al., 2000) . However, the effects and molecular mechanisms underlying the action of all-trans retinoic acid (tRA) on acute UVinduced angiogenesis in human skin have not been studied.
In this study, we examined VEGF expression after administering by a single dose of UV radiation to HaCaT cells and to human skin epidermis, and sought to identify the signaling molecules involved in UV-induced VEGF expression. In addition, we investigated the effects of tRA on VEGF expression and cutaneous vascularity after single UV exposure in vitro and in vivo experimental systems.
RESULTS

VEGF levels are increased by UV irradiation in keratinocytes
To investigate the effect of UV on VEGF expression in the human keratinocyte cell line HaCaT, cells were irradiated with 50 mJ/cm 2 of UV and harvested at different times (2-10 h) after UV irradiation. To examine UV-induced VEGF secretion, supernatants were checked for VEGF protein at different time points by ELISA ( Figure 1a ). Released VEGF protein levels were significantly increased by approximately 3.6-fold in UV-irradiated conditioned medium versus shamirradiated control medium 6 hours post-UV, and this was maintained at 8 hours post-UV. As shown in Figure 1b , a low level of VEGF mRNA was detected in quiescent, nonirradiated cells and VEGF mRNA expression peaked at 4 hours post-UV by 2.1-fold versus the sham-irradiated control cells.
The MEK-ERK1/2 pathway involves UV-induced VEGF upregulation in keratinocytes
To determine the mechanisms underlying VEGF regulation in response to UV exposure, we attempted to identify the pathways involved in the regulation of VEGF expression post-UV in HaCaT cells. Extracellular signal-regulated kinase 1/2 (ERK1/2) activation and Akt activation were observed in previous study. We pretreated cells for 30 minutes with either a specific MAPK/ERK kinase (MEK) inhibitor, U0126 (Favata et al., 1998) , or a specific phosphatidylinositol 3-kinase PI3K inhibitor, wortmannin (Powis et al., 1994) prior to UV. Cells were harvested at 2 hours post-UV. As shown in Figure 2a , these pretreatments were found to inhibit the downstream targets, ERK1/2 or Akt. U0126 (20 mM) blocked ERK1/2 activation, and wortmannin (50 nM) blocked Akt activation. Wortmannin had no effect on ERK phosphorylation and U0126 had no effect on Akt phosphorylation.
To investigate the involvements of these signaling pathways on UV-induced VEGF expression, we examined VEGF expressions in the presence and absence of specific inhibitors. VEGF levels secreted from cells pretreated with/ without U0126 or wortmannin for 30 minutes prior to UV irradiation were analyzed by ELISA. The amounts of VEGF released into culture media 6 hours post-UV from cells was almost 3.8-fold increase compared with cells not exposed to UV. This UV-induced VEGF release was significantly inhibited by U0126 (81% inhibition), but not by wortmannin (Figure 2b ). The effect of ERK inhibition on VEGF mRNA expressions was similar to that of protein expression at 4 hours post-UV (Figure 2c ). U0126 completely inhibited UVinduced VEGF mRNA expression to the basal mRNA level, whereas wortmannin had no inhibitory effect on UV-induced VEGF upregulation. These findings demonstrate that the MEK-ERK pathway positively modulates VEGF expression in UV-irradiated keratinocytes.
tRA inhibits UV-induced VEGF expression and ERK1/2 activation in keratinocytes
We next investigated the effects of tRA on UV-induced VEGF release and ERK activation. HaCaT cells were treated with vehicle (0.005% DMSO) or tRA (10 À9 M) for 24 hours prior to UV exposure (50 mJ/cm 2 ), and VEGF levels in supernatant were measured by ELISA 6 hours post-UV (Figure 3a ). Basal VEGF secretion was reduced by 44.1% by tRA in nonirradiated cells and tRA completely blocked UV-induced VEGF release. We next examined the effect of tRA on UV-induced ERK1/2 phosphorylation. Cells were treated with vehicle or tRA (10 À9 M) for 24 hours prior to UV exposure (50 mJ/cm 2 ), and harvested at 2 hours post-UV (Figure 3b ). Pretreatment with tRA obviously inhibited ERK1/2 activation, in nonirradiated cells and irradiated cells. These data indicate tRA can inhibit UV-induced activation of ERK1/2 protein following VEGF upregulation in human keratinocytes. To observe the effects of UV irradiation on angiogenesis and VEGF expression in human skin in vivo, sun-protected buttock skin (n ¼ 3) was exposed to a single dose of UV radiation (2 MED). Skin samples were obtained after 1, 2, and 3 days. Routine haematoxylin and eosin staining revealed obvious epidermal hyperplasia and an increased epidermal thickness after UV exposure. Moreover, inflammatory cell recruitment was observed in the upper dermis as compared with normal nonirradiated skin (Figure 4a) .
Immunohistochemistry for endothelial cell adhesion molecule CD31 (PECAM-1) revealed a progressive increase in the number of enlarged vessels in UV-irradiated skin compared with untreated control skin (Figure 4b ). Computer-assisted quantitative image analysis of CD31-stained cutaneous vessels was performed to quantify cutaneous vessel numbers and sizes. Three different fields per section were examined, and the number of vessels per mm 2 , average vessel size, and the relative area occupied by blood vessels were determined within 200 mm from the epidermal-dermal junction. Vascular densities were found to be significantly increased on day 2 (52.6% increase) and on day 3 (50.5% increase) after UV irradiation compared with nonirradiated skin (Figure 4c ). In addition, average vessel size was significantly increased on day 1 (45.3% increase), day 2 (57.2% increase), and day 3 (90.2% increase) post-UV ( Figure 4d ). Consequently, the cutaneous area covered by blood vessels located within 200 mm from epidermal-dermal junction gradually increased from 1.5% in normal skin to 4.3% in UV-irradiated skin on day 3 (Figure 4e ). These changes in neovascularization were accompanied by increased endothelial cell proliferation (data not shown), and were prominent in the papillary dermis, which immediately underlies the epidermis.
VEGF is upregulated by a single exposure to UV in human skin epidermis
The effects of acute UV irradiation on epidermal VEGF expression in sun-protected buttock skin were examined by immunohistochemistry, Western blotting, and semiquantitative RT-PCR. Whereas VEGF expression was low in nonirradiated control skin, it was strongly expressed in the granular layer day 1 post-UV (2 MED) irradiation (n ¼ 3). On days 2 and 3 post-UV, VEGF expression was distributed throughout the epidermis (Figure 5a ). Western blot analyses of epidermis showed that VEGF expressions were significantly increased on days 2 and 3 post-UV (n ¼ 5, Figure 5b ). As shown in Figure 5c , VEGF mRNA was also overexpressed on day 1 post-UV versus nonirradiated skin (n ¼ 5). To investigate the involvement of the ERK pathway, human buttock skin was irradiated with 2 MED of UV and skin biopsies were obtained from each subject at 2, 4, and 8 h, and on days 1, and 2 post-UV. A significant increase in ERK phosphorylation was observed at 4 and 8 hours post-UV and this returned to its basal level at 2-day post-UV (n ¼ 4, Figure  5d ). UV exposure did not alter total ERK levels at these times, and like HaCaT cells, the epidermis expressed considerably more ERK2 than ERK1.
tRA inhibits UV-induced angiogenesis and VEGF upregulation in human skin in vivo
We investigated whether pretreating human skin with tRA could inhibit UV-induced cutaneous angiogenesis. Human buttock skin (n ¼ 4) was treated with vehicle and tRA www.jidonline.org 2699 (0.025%) for 48 hours before UV irradiation (2 MED) under occlusion. Skin samples were obtained at 48 hours after UV irradiation and dermal vascularization was analyzed by immunohistochemistry of CD31 (Figure 6a ). tRA applied for 4 days to normal skin tended to increase the vascularity of the dermis. Topical application of tRA before UV irradiation significantly inhibited UV-induced angiogenesis as determined by vessel density (Figure 6c , 86.8% inhibition) and by vessel area (Figure 6d , 64.6% inhibition), as compared with skin pretreated with vehicle and exposed to UV. However, tRA pretreatment did not affect UV-induced vessel size increases (Figure 6b) .
We next examined the effects of tRA on UV-induced VEGF protein and mRNA expression, and ERK1/2 phosphorylation. Human buttock skin was pretreated with vehicle and tRA (0.025%) for 48 hours before UV irradiation (2 MED) under occlusion, and skin samples were obtained 48 hours post-UV. Immunohistology revealed that UV induced VEGF protein throughout the epidermis and that tRA pretreatment substantially inhibited UV-induced VEGF expression versus vehicletreated, UV-irradiated skin (n ¼ 4, Figure 7a ). Epidermis thickness increases after UV irradiation and slightly inhibited by tRA pretreatment. Moreover, the pretreatment of human skin with tRA blocked UV-induced mRNA overexpression of VEGF (n ¼ 3, Figure 7b ). Owing to maximal ERK activation was observed 4 or 8 hours post-UV (Figure 5d ), skin samples were obtained at 8 hours post-UV and ERK phosphorylation levels in epidermis were analyzed (n ¼ 3, Figure 7c ). Topical pretreatment with tRA was found to significantly inhibit UVinduced ERK1/2 activation versus vehicle-treated, UV-irradiated skin. These results indicate that topical treatment with tRA can prevent acute UV response by inhibiting UV-induced ERK1/2 activation, VEGF upregulation, and angiogenesis. DISCUSSION Angiogenesis has remained a major focus of cancer research for the past two decades. However, the vascular changes are also the clinical characteristics of noncancerous skin diseases like rosacea and psoriasis (Bhushan et al., 2002) . A recent animal study suggested that skin angiogenesis plays a critical role in photoaging, and that the inhibition of angiogenesis diminishes UVB-induced wrinkle formation . Although neovascularization is a typical reaction of UV-associated skin diseases, the mechanism underlying human skin angiogenesis remains unclear.
The level of VEGF, the major angiogenic factor, is important parameter in maintaining balanced skin angiogenesis. It has been identified as a major keratinocyte-derived , the average vessel size, and the relative area occupied by blood vessels were determined in the papillary dermis. Data are presented as means7SEM for three subjects. *Po0.05 versus nonirradiated normal skin (Wilcoxon Signed-Rank test).
vessel-specific growth factor (Detmar et al., 1995) , and the expression has been reported to be upregulated in the hyperplastic epidermis of psoriasis (Detmar et al., 1994) , in keloids (Gira et al., 2004) , in basal cell carcinoma (Oh et al., 2003) , squamous cell carcinoma (Bowden et al., 2002) , melanoma (Gorski et al., 2003) , and in chronic wounds (Lauer et al., 2000) . Recently, efforts have being made to reduce VEGF levels for antiangiogenic and antitumor therapy. Thus, studies on the regulation of VEGF in skin provide a basic understanding that can be used for the . Acute UV exposure induced VEGF overexpression and ERK1/2 activation in human skin epidermis. Sun-protected buttock skin was exposed to a single dose of UV (2 MED). Samples were obtained by punch biopsy at the indicated times post-UV. (a) Immunostaining for VEGF was performed on frozen sections (n ¼ 3). Bar ¼ 100 mm. (b) Protein extracts from epidermis were analyzed by Western blotting using antibody for VEGF (n ¼ 5). Epidermis was separated from dermis with a forceps after incubating skin samples at 581C for 2 minutes in PBS. (c) Semiquantitative RT-PCR showed changes in VEGF mRNA expressions in the epidermis (n ¼ 5). The products of VEGF were of 516, 648, and 730 bp, and those of GAPDH were 565 bp, respectively. (d) The time-dependent effect of UV on ERK1/2 activation was investigated in epidermis (n ¼ 4). The results from all subjects were analyzed by densitometry (normalization by actin or GAPDH) in the lower panels and results are presented as means7SEM for all subjects. *Po0.05 versus nonirradiated normal skin (Wilcoxon Signed-Rank test).
www.jidonline.org 2701 development of treatments for angiogenesis-associated skin diseases.
In this study, we found that UV induces VEGF overexpression in HaCaT keratinocytes and in the epidermis of human skin. According to recent reports, the PI3K-Akt pathway and the Ras-p42/p44 mitogen-activated protein kinase (ERK1/2) signaling pathway play important regulatory roles in angiogenesis (Berra et al., 2000; Segrelles et al., 2004) . Therefore, we investigated whether or not ERK1/2 and Akt pathways are involved in UV-induced VEGF production in keratinocytes. Our results show that UV-induced VEGF overexpression was suppressed by U0126, a specific MEK inhibitor, but not by wortmannin, a specific PI3K inhibitor, which suggests that the MEK-ERK1/2 pathway is involved in UV-stimulated VEGF upregulation in keratinocytes. In addition, tRA remarkably inhibited the UV-induced ERK1/2 activation and VEGF overexpression in keratinocytes.
It has been reported that UV can induce VEGF upregulation in immortalized HaCaT cells developed from human adult skin keratinocytes (Fusenig and Boukamp, 1998) . It has been demonstrated that the first induction of VEGF by UVB is regulated in a coordinated fashion by the activation of epidermal growth factor receptor and subsequent delayed release of TGF-a (Blaudschun et al., 2000) . It was also reported that several stimulators induced VEGF upregulation via mitogen-activated protein kinase signal transduction pathways in keratinocytes. Recently, treatment of HaCaT keratinocytes with insulin-like growth factor-II (IGF-II) was reported to probably activate a single mitogen-activated protein kinase pathway, that is, an ERK pathway, but not a p38 or JNK pathway, and that this increasesd VEGF expression (Kwon et al., 2004) . Moreover, it was *demonstrated that IGF-II induces VEGF gene expression via tyrosine kinase-Src-ERK1/2 and PI3K pathways in HaCaT keratinocytes (Kim and Kim, 2005) . In addition, VEGF secretion was found to be regulated by tyrosine kinase-Src-ERK1/2, but this secretion was independent of PI3K. Another stimulator, hepatocyte growth factor/scatter factor, may functions as a potent inducer of VEGF expression in keratinocytes (Gille et al., 1998) . Hepatocyte growth factor/scatter factor-induced specificity protein 1 phosphorylation was suggested to activate VEGF promoter activity, which requires contributions by distinct signaling molecules, such as PI3K, ERK1/2, and PKCz (Reisinger et al., 2003) . The results of the present study show that UV-induced VEGF upregulation occurs via MEK-ERK1/2 activation and not via PI3K-Akt activation in human keratinocytes, and indicate that signal transduction pathways associated with VEGF regulation depend on specific stimulations in keratinocytes. It is well known that retinoids regulate cell differentiation, proliferation and apoptosis. In addition, they have been shown to inhibit angiogenesis in vitro and in vivo experiments (Liaudet-Coopman et al., 1997; Pal et al., 2000) . Such antiangiogenic effects of retinoids may be the result of alterations in the activities of endothelial cells, for example, the inhibition of endothelial cell migration, and in the production of factors that stimulate or inhibit vessel growth. In this study, we observed the inhibition of basal VEGF expression by tRA in HaCaT keratinocytes. This inhibitory effect is consistent with other reports that demonstrated that RA inhibits spontaneous VEGF production in primary cultured human normal keratinocytes (Weninger et al., 1998; Lachgar et al., 1999) . tRA has been reported to stimulate or suppress the activation of mitogen-activated protein kinase signaling pathways in different cell models (Alsayed et al., 2001; Kunisada et al., 2005) . Our results show that tRA inhibits UV-induced VEGF expression via ERK1/2 downregulation in keratinocytes. However, in contrast to our results concerning the inhibitory effect of tRA on VEGF expression, it was suggested that RA stimulates the release of VEGF via ERK1/2 activation in aortic smooth muscle cells (Tanabe et al., 2004) . The reasons of this discrepancy and how RA affects ERK activation still remain to be investigated. Further studies are needed to understand the molecular mechanism of the inhibitory effects of tRA on UV-induced ERK1/2 activation.
Topical retinoids are widely used to treat psoriasis and rosacea, which suggests that VEGF has a pathogenic role (Rolewski, 2003) . Topical retinoid therapy is also used to reverse some of the effects of photoaging (Stratigos and Katsambas, 2005) . The long-term application of tRA dramatically changes the skin architecture; it increases epidermal thickness, facilitates the depositions of extracellular matrix proteins, and increases dermal vascularity. The short-term application of tRA (for 4 days) to buttock skin in this study also tended to increase dermal vascularity and epidermal VEGF expression. These findings contradict the in vitro results concerning the inhibition of basal VEGF expression by tRA in keratinocytes. It is possible that the effects of tRA treatment in keratinocytes in vitro differ from its effects when applied topically to epidermis in human skin in vivo.
Our results show that (i) tRA inhibits basal VEGF expression in keratinocytes in vitro, but induces VEGF expression in human skin epidermis in vivo; (ii) tRA blocks UV-induced VEGF expression both in vitro and in vivo; and (iii) that this inhibitory effect of tRA depends on the inhibition of ERK1/2 phosphorylation in signaling pathways. Thus, our results indicate that tRA has an inhibitory effect on UVinduced angiogenesis via the downregulation of VEGF signaling. These findings demonstrate that tRA is a potent inhibitor of the angiogenesis caused by UV exposure, and that it might be a useful therapeutic agent against angiogenesis-associated photo-damages.
Despite recent advances in our understanding of angiogenesis, many questions remain unanswered. Further studies are needed to characterize the relationship between skin angiogenesis and the skin damage induced by UV. In addition, we need to know whether RA can regulate other angiogenic factors and signaling molecules that alter the molecular balance for angiogenesis in human skin.
In conclusion, our study demonstrates for the first time that acute exposure to UV radiation triggers angiogenesis via VEGF induction and MEK-ERK1/2 activation, and that tRA inhibits UV-induced ERK1/2 activation, VEGF upregulation, and angiogenesis in human skin (Figure 8 ). Thus, a strategy based on VEGF inhibition after UV exposure may prevent or arrest the evolution of skin damages associated with UV, which are characterized by increased vascular permeability and angiogenesis. An understanding of the cascade of molecular signals in UV-induced signaling pathways may provide us with new insights and therapeutic target molecules that allow the prevention of angiogenesis-associated skin photo-damages.
MATERIALS AND METHODS
Reagents and antibodies
Cell culture medium, DMEM, and fetal bovine serum were purchased from Gibco BRL (Grand Island, NY), and U0126, wortmannin and tRA ( www.jidonline.org 2703
antibody, and recombinant VEGF were obtained from R&D Systems (Minneapolis, MN).
Cell culture and UV exposure
The human epidermal cell line, HaCaT, was cultured in DMEM supplemented with 10% fetal bovine serum, penicillin (400 U/ml), streptomycin (50 mg/ml), and glutamine (2 mM), and grown on plastic tissue culture dishes in a humidified 5% CO 2 atmosphere at 371C. A Waldmann broad-band UVB (Waldmann, Villingen-Schwenningen, Germany) phototherapy device equipped with F85/100W/UV21 fluorescent sunlamps with an emission spectrum between 285 and 350 nm (peaking 313 nm) was used as the UV source. A Kodacel filter (TA401/407, Kodak, Rochester, NY) was mounted 5 cm in front of the UV lamps to remove wavelengths of less than 290 nm (UVC). UV intensity was measured using a Waldmann UV meter (Model No. 585100). In order to avoid interference due to the cytotoxic effect of UV, MTT assays were performed to determine the optimal noncytotoxic dose (40-100 mJ/cm 2 ). Subconfluent monolayer cultures of serum-starved HaCaT cells (2 Â 10 5 cells/ml) were rinsed with phosphate-buffered saline (PBS) and thereafter irradiated under a thin layer of PBS at a UV dose of 50 mJ/cm 2 . Sham-irradiated control cells were handled in an identical manner, but were not exposed to UV. After irradiation, media were replenished with fresh DMEM medium without fetal bovine serum, and cells were cultured for various times. In experiments involving treatment with inhibitors, cells were pretreated with 20 mM U0126 (a specific MEK inhibitor) or 50 nM wortmannin (a specific PI3K inhibitor) for 30 minutes before UV irradiation. In experiments involving tRA, cells were preincubated with 10 À9 M tRA for 24 hours before UV irradiation. All reagents were dissolved in DMSO, and cells were treated with the same amounts of DMSO in medium before UV irradiation.
Measurement of VEGF secretion
After UV irradiation, cell-free supernatants were collected and stored at À701C until required for cytokine assay. Secreted VEGF levels in the culture media of HaCaT cells were determined by sandwich ELISA, according to the manufacture's protocol (R&D systems). Absorption of avidin-horseradish peroxidase color reaction was measured at 405 nm and VEGF concentrations were determined using a standard graph prepared using serial dilutions of human recombinant human VEGF as a standard.
Human skin samples
Eighteen Korean volunteers (17 men and 1 woman, mean age 28.071.3 year, age range 20-36 year) without current or prior skin disease were enrolled in the study. For UV exposure, we used the device described above for in vitro study. The MED for each subject was determined 24 hours after irradiation. Usually, the MED measured for filtered UV was around 70-90 mJ/cm 2 . The phototypes of the volunteers include types III, IV, and V. Irradiated (2 MED of UV) and nonirradiated buttock skin samples were obtained from each subject by punch biopsy at the indicated time points after UV irradiation. The samples were placed immediately into a cryomatrix (Shandon, Pittsburgh, PA) for immunohistochemical staining and into liquid nitrogen for Western blotting, and all samples were stored at À701C until required. This study was conducted according to the Declaration of Helsinki Principles. All procedures involving human subjects were approved by the Institutional Review Board at the Seoul National University Hospital, and all subjects provided written informed consent.
tRA preparation and topical application tRA was freshly emulsified in polyethyleneglycol 400 (PEG 400) and maintained at 41C in dark tubes. The buttock skins of young subjects were treated with 0.025% tRA and vehicle (62.5 ml/cm 2 ) under occlusion for 48 h, and then treated skins were irradiated with 2 MED of UV. Skin samples were obtained at 8 hours (for ERK analysis) or 48 hours (for VEGF and vascularization analysis) post-UV from each subject by punch biopsy.
Western blotting analysis
After irradiated and non-irradiated buttock skin samples had been obtained from each subject by punch biopsy, epidermis and dermis were separated using a forceps after incubating skin samples at 581C for 2 minutes in PBS. Soluble protein was extracted from epidermis and HaCaT cells using a lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1% Triton X-100, 75 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM DTT, and protease inhibitor cocktail (Sigma-Aldrich). The protein concentrations of extracts were measured by BCA protein dye reagent. VEGF levels were determined in protein extracts from epidermis samples and HaCaT cells. Samples were loaded and separated on 10% SDS-polyacrylamide gels, and proteins were electrotransferred onto nitrocellulose membranes (Amersham Pharmacia) at 41C. Membranes were then blocked with 5% nonfat dry milk in PBS containing 0.1% Tween-20 (PBST) for 1 h, and after a brief wash with PBST, membranes were probed with primary antibody for 1 h, and washed three times with PBST. They were then treated with horseradish peroxidase-conjugated secondary antibody for 45 minutes and blots were detected using ECL detection reagent (Amersham Biosciences, Piscataway, NJ). Proteins were visualized by fluorography using Agfa X-ray film blue. Bands were quantified using a densitometric program (Bio 1D; Vilber Lourmat, Torcy Z.I., France).
Semiquantitative RT-PCR
Total RNA was extracted from tissues and cells using TRI ZOL reagent (Invitrogen Life Technologies, Carlsbad, CA), and 1 mg of total RNA was converted to cDNA using reverse transcriptase at 371C for 1 hours (First Strand cDNA Synthesis Kit, Fermentas, Hanover, MD). PCR reactions were performed using 0.5-2 ml of cDNA and prealiquoted ReddyMix TM PCR master mix (Abgene, Surrey, UK). Optimal semiquantitative conditions were set to fall in the linear PCR product range (data not shown). PCR consisted of 34 amplification cycles (941C, 30 seconds; 601C, 30 seconds; 721C, 1 min) for human VEGF using oligonucleotide primer sets. In parallel, the GAPDH gene was amplified in each RNA sample as an internal control. The VEGF primers used were 5 0 -CCA TGA ACT TTC TGC TGT CTT-3 0 (forward) and 5 0 -TCG ATC GTT CTG TAT CAG TCT-3 0 (reverse), and the GAPDH primers used were 5 0 -ATT GTT GCC ATC AAT GAC CC-3 0 (forward) and 5 0 -AGT AGA GGC AGG GAT GAT GT-3 0 (reverse). The primer sets used yielded PCR products of 516, 648 and 730 bp for VEGF 121 , VEGF 165 , and VEGF 189 , respectively. PCR products were electrophoresed on 1.8% agarose gels and visualized with ethidium bromide. Signal strengths were quantified using a densitometric program (Bio 1D; Vilber Lourmat, Torcy Z.I., France).
Immunohistochemistry
Frozen human skin tissues were examined for VEGF and CD31 expression as described previously (Chung et al., 2002) . Briefly, snap-frozen tissues were placed immediately into a cryomatrix (Shandon, Pittsburgh, PA), stored at À701C, sectioned at 4 mm, mounted onto silane-coated slides (Dako, Glostrup, Denmark), and acetone fixed at À201C for 15 min. The frozen sections were then rehydrated in DW and endogenous peroxidase activity was quenched using 3% hydrogen peroxide for 10 min. The sections were then blocked with blocking solution (Zymed, San Francisco, CA) for 30 min, and washed and incubated with primary antibodies in a humidified chamber at 41C for 18 h. After washing in PBS, they were incubated with biotinylated secondary antibody for 30 min, followed by horseradish-streptoavidin conjugate for 15 min. After a further washing in PBS, color was developed using AEC (3-amino-9-ethylcarbazole; Zymed) for 5-10 min. The sections were then washed in running tap water for 5 min, and cell nuclei were counterstained with Mayer's hematoxylin (Dako). The cutaneous blood vessel numbers and diameters were captured and analyzed using an image analysis program (Vedio Test-Master Morphology, Image and Microscope Technology, Korea). Vessel numbers per mm 2 , average vessel sizes, and the relative areas occupied by vessels were determined in dermis. Three different Â 200 fields within 200 mm from the epidermal-dermal junction were examined in the dermis of each section.
Statistics
Results are expressed as means7SEM of independent experiments, and all experiments were repeated at least four times. The significance of differences between independent two groups was analyzed using the Mann-Whitney U-test and that of differences between dependent two groups was analyzed using the Wilcoxon Signed-Rank test. For all tests, a P-value of o0.05 was considered statistically significant. All data were analyzed using SPSS 11.0 for Windows (SPSS Inc., Chicago, IL).
